Family History

460 articles

Research
August 1, 2019 • 4 Min

New Study Combines Checkpoint Inhibitors with Radiation Therapy to Boost Immune Response

Dr. Theodore Hong combines checkpoint inhibitors–a type of immunotherapy–with radiation to boost the immune system in pancreatic cancer treatment.

Research
July 8, 2019 • 5 Min

Pancreatic Cancer Patients in the UK Benefit From Unique Precision Medicine Project

Dr. David Chang explains the Precision Panc initiative, a program through the UK’s NHS that helps pancreatic cancer patients find treatments.

Research
March 26, 2019 • 4 Min

Damage as a Way to Repair Pancreatic Cancer

Dr. Talia Golan takes a closer look at the damage caused by the BRCA1/2 mutations to find a way to treat pancreatic cancer.

Research
August 24, 2018 • 5 Min

New Research Sheds Light on Hot and Cold Tumors

Dr. Ben Z. Stanger and his team are finding links between the number of T cells a tumor has and the effectiveness of immunotherapy.

Research
October 12, 2022 • 6 Min

Exercise Helps Boost Immune System and Immunotherapy Treatment

Dr. Emma Kurz is part of a research team that has found that exercise can help make immunotherapy more effective for pancreatic cancer.

Research
February 27, 2018 • 3 Min

Precision Medicine from the Get-Go for Pancreatic Cancer

Dr. Ben George and colleagues at the Medical College of Wisconsin are using molecular profiling to determine the best chemotherapy for a patient’s pancreatic cancer.

Research
November 8, 2016 • 4 Min

BRCA’s Role in Pancreatic Cancer Investigated

The relationship between BRCA and pancreatic cancer, and how that affects treatment, is the focus of clinical trials looking at PARP inhibitors.

Research
May 23, 2016 • 5 Min

A Liquid Biopsy for Pancreatic Cancer

Dr. Bert Vogelstein and his team at Johns Hopkins are working with a blood test called a liquid biopsy, which tests cells for mutations related to cancer.

Research
June 21, 2021 • 3 Min

CRISPR-Engineered Immunotherapy for Metastatic GI Tract Cancers

CRISPR technology is used as part of an immunotherapy clinical trial for metastatic pancreatic cancer and other GI cancers.

Research
May 25, 2021 • 2 Min

PARP Inhibitor as Maintenance for Pancreatic Cancer Patients with BRCA1, BRCA2, or PALB2 Mutations

A new clinical trial tests a PARP inhibitor as maintenance treatment for pancreatic cancer patients with BRCA1/2 or PALB2 mutations.

Survivor Stories
October 25, 2018 • 1 Min

Just Continue to Fight

Roberta Luna has been fighting pancreatic cancer for 15 years. She lost both her parents, her uncle, and her grandmother to the disease but she keeps on fighting.

Survivor Stories
February 18, 2018 • 1 Min

Finding Your Own Hope: A Seven-Year Survivor of Pancreatic Cancer

Nancy is a 7-year survivor of pancreatic cancer. Watch the video to hear what she says about battling pancreatic cancer and being a long-term survivor.

Research
November 6, 2020 • 2 Min

An Expanded Access Trial for Cancer Patients with Specific Mutations

An investigational drug is being used in an expanded access trial for advanced pancreatic and other cancer patients with specific genetic changes.

Research
January 16, 2017 • 2 Min

Comparing a Standard Chemotherapy With and Without a PARP Inhibitor

A clinical trial compares standard chemotherapy with and without the addition of a PARP inihibitor, for patients whose pancreatic cancer is spreading again.

Survivor Stories
February 25, 2019 • 3 Min

If Something Feels Wrong, Insist on Testing

Kristin Sine wanted an answer to her mysterious pain, but she had to insist on testing to find out she had a pancreatic neuroendocrine tumor.